Memorial Sloan-Kettering Cancer Center (MSKCC)

Memorial Sloan Kettering Cancer Center (MSK or MSKCC) is a cancer treatment and research institution founded in 1884 as the New York Cancer Hospital.

The promise of stem cell technologies for treating Parkinson’s

Despite challenges, new advances in stem cell biology and genetic engineering show potential for better cell replacement therapies, say experts in a special supplement to JPD Cell replacement may play an increasing role in alleviating the motor symptoms of Parkinson’s disease (PD) in future. Writing in an open access special supplement to the Journal of Parkinson’s Disease, experts describe how

The promise of stem cell technologies for treating Parkinson’s

Fecal microbiota transplantation could offset harsh effects of antibiotics in cancer patients

NIAID-funded study could offset harsh effects of antibiotics. Researchers at Memorial Sloan Kettering Cancer Center have shown that autologous fecal microbiota transplantation (auto-FMT) is a safe and effective way to help replenish beneficial gut bacteria in cancer patients who require intense antibiotics during allogenic hematopoietic stem cell transplantation. In their study, patients who underwent the

Fecal microbiota transplantation could offset harsh effects of antibiotics in cancer patients

Using ultrasound to remotely control a cancer immunotherapy system

A team of researchers has developed an ultrasound-based system that can non-invasively and remotely control genetic processes in live immune T cells so that they recognize and kill cancer cells. There is a critical need to non-invasively and remotely manipulate cells at a distance, particularly for translational applications in animals and humans, researchers said. The

Using ultrasound to remotely control a cancer immunotherapy system

Complete cure for colorectal cancer?

Novel three-step pretargeted radioimmunotherapy offers safe, effective treatment Researchers at Memorial Sloan Kettering Cancer Center in New York City and Massachusetts Institute of Technology in Boston have developed a new, three-step system that uses nuclear medicine to target and eliminate colorectal cancer. In this study with a mouse model, researchers achieved a 100-percent cure rate—without any

Complete cure for colorectal cancer?

A new way to combat cancer at the cellular level: Block it

New findings published in Nature Chemical Biology show promise for finding new solutions to treat lung cancer and other deadly diseases. Kentucky continues to lead the nation in incidence and death rates from lung cancer, and the University of Kentucky is committed to reducing these numbers. According to the National Cancer Institute, cancer is among the leading causes

A new way to combat cancer at the cellular level: Block it

A single gene turns colorectal cancer cells back into normal tissue in mice

Anti-cancer strategies generally involve killing off tumor cells. However, cancer cells may instead be coaxed to turn back into normal tissue simply by reactivating a single gene, according to a study published June 18th in the journal Cell. Researchers found that restoring normal levels of a human colorectal cancer gene in mice stopped tumor growth and

A single gene turns colorectal cancer cells back into normal tissue in mice

‘Huge breakthrough’ in understanding how the immune system recognises cancer

US researchers have revealed(link is external) the identity of molecules on the surface of cancer cells which allow the body’s immune system to identify and destroy them. The research could lead to a new generation of immunotherapies that are far more effective than those currently in use, that could target a range of cancers. “This

‘Huge breakthrough’ in understanding how the immune system recognises cancer

Handheld scanner could make brain tumor removal more complete, reducing recurrence

Cancerous brain tumors are notorious for growing back despite surgical attempts to remove them — and for leading to a dire prognosis for patients. But scientists are developing a new way to try to root out malignant cells during surgery so fewer or none get left behind to form new tumors. The method, reported in

Handheld scanner could make brain tumor removal more complete, reducing recurrence

Genetically Modified T Cells Induced Complete Remissions in 88 Percent of Advanced Leukemia Patients Treated

Cell Therapy Shows Remarkable Ability to Eradicate Cancer in Clinical Study Investigators from Memorial Sloan Kettering Cancer Center have reported more encouraging news about one of the most exciting methods of cancer treatment today. The largest clinical study ever conducted to date of patients with advanced leukemia found that 88 percent achieved complete remissions after being treated

Genetically Modified T Cells Induced Complete Remissions in 88 Percent of Advanced Leukemia Patients Treated

Copper Surfaces Reduce the Rate of Healthcare-Acquired Infections in the ICU

Placement of copper objects in intensive care unit (ICU) hospital rooms reduced the number of healthcare-acquired infections (HAIs) in patients by more than half Placement of copper objects in intensive care unit (ICU) hospital rooms reduced the number of healthcare-acquired infections (HAIs) in patients by more than half, according to a new study published in

Copper Surfaces Reduce the Rate of Healthcare-Acquired Infections in the ICU

New Breakthrough Prize Awards Millions to Life Scientists

Eleven scientists became multimillionaires this morning when they were named the first winners of the new Breakthrough Prize in Life Sciences. Each researcher, whose specialties include genetics, stem cells, and cancer, will receive $3 million dollars, more than twice the maximum amount of a Nobel Prize. Funded by several Silicon Valley entrepreneurs, including Arthur Levinson

New Breakthrough Prize Awards Millions to Life Scientists

Potential Cancer Diagnostic Tool Set for Human Trials

The U.S. Food and Drug Administration (FDA) has approved the first clinical trial in humans of a new technology: Cornell Dots, brightly glowing nanoparticles that can light up cancer cells in PET-optical imaging. A paper describing this new medical technology is published online in the Journal of Clinical Investigation (July 2011). This is a collaboration

Potential Cancer Diagnostic Tool Set for Human Trials

The Latest Bing News on:

Memorial Sloan-Kettering Cancer Center (MSKCC) Research

Can Virtual Patients Lead to Better Cell Therapies?
Biosimulation leader Certara recently inked a deal with a leading cancer research institution. Does it matter to investors?
Conference Casts a Wide Net to Reach the Whole Cancer Team
Ajai Chari, MD, explains oncologists should expect from the upcoming 40th Annual CFS Innovative Therapy for Tomorrow.
Weill Cornell's cancer center names Dr. Jedd Wolchok director
Weill Cornell Medicine has selected Jedd Wolchok, MD, as the Meyer Director of the Sandra and Edward Meyer Cancer Center. Dr. Wolchok is an internationally acclaimed medical oncologist and ...
Melanoma specialist appointed director of cancer center at Weill Cornell Medicine
Jedd Wolchok, MD, PhD, FASCO, has been appointed director of Meyer Cancer Center at Weill Cornell Medicine.Wolchok, a medical oncologist whose work in immunotherapy has helped to transform melanoma ...
NeoPhore inks three year research collaboration with Memorial Sloan Kettering Cancer Center to determine potential of proprietary DNA MMRi compounds
NeoPhore inks three year research collaboration with Memorial Sloan Kettering Cancer Center to determine potential of proprietary DNA MMRi compounds: Cambridge, UK Friday, July 29 ...

The Latest Google Headlines on:

Memorial Sloan-Kettering Cancer Center (MSKCC) Research

The Latest Bing News on:

Memorial Sloan-Kettering Cancer Center (MSKCC) Discovery

NJ’s top hospitals again celebrate U.S. News rankings
Some of NJ's most highly regarded health care facilities retained their bragging rights on the latest U.S. News best hospitals list.
Physics Particles Fly as Practical Tools
Protons, muons, neutrinos and other particles are moving beyond the realm of physics to help in a myriad of ways ...
NeoPhore inks three year research collaboration with Memorial Sloan Kettering Cancer Center to determine potential of proprietary DNA MMRi compounds
NeoPhore inks three year research collaboration with Memorial Sloan Kettering Cancer Center to determine potential of proprietary DNA MMRi compounds: Cambridge, UK Friday, July 29 ...
Dr. Jedd Wolchok Appointed Meyer Director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine
Dr. Jedd Wolchok, an internationally acclaimed medical oncologist whose innovations in immunotherapy have revolutionized melanoma treatment, has been recruited as the Meyer Director of the Sandra and ...
Certara Announces Collaboration with Leading Cancer Center to Advance CAR T-cell Therapies
Certara and Memorial Sloan Kettering Cancer Center to develop biosimulation platform for CAR T-cell therapies. Certara, Inc. (Nasdaq: CERT), a global leader in ...